Supernus Pharmaceuticals Inc. (SUPN)

Supernus Pharmaceuticals Inc. (SUPN $55.70)
- $55.70 P/E (TTM): 47.94X Cap: $3.09B
- View SUPN Profile
- View Questions on SUPN

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Supernus Pharmaceuticals Inc. (SUPN $55.70)
- $55.70 P/E (TTM): 47.94X Cap: $3.09B
- View SUPN Profile
- View Questions on SUPN

Q: Could you give your analysis of SUPN. Is it a buy now? Thanks

Read Answer Asked by Bruce on February 15, 2019

Supernus Pharmaceuticals Inc. (SUPN $55.70)
- $55.70 P/E (TTM): 47.94X Cap: $3.09B
- View SUPN Profile
- View Questions on SUPN
ANI Pharmaceuticals Inc. (ANIP $94.06)
- $94.06 Cap: $2B
- View ANIP Profile
- View Questions on ANIP

Q: Hi,
I am thinking to buy one of these.
What would be better buy and why?

Thank you.
Milan

Read Answer Asked by Milan on February 01, 2018

Supernus Pharmaceuticals Inc. (SUPN $55.70)
- $55.70 P/E (TTM): 47.94X Cap: $3.09B
- View SUPN Profile
- View Questions on SUPN

Q: What are your thoughts on Supernus Pharmaceuticals? Does insider selling concern you? What would be an appropriate weighting for an aggressive portfolio? Does the positive price action provide insight to additional short term gains? Thanks

Read Answer Asked by Gooding on January 19, 2018